Authors
Discussion
Loading...
Member takes
Implication
Epidemiological review demonstrates advances in diagnostics, drugs, and vaccines against 8.7 million active tuberculosis cases, highlighting improved prospects for global disease control.
Key Points
- To assess the global burden of active tuberculosis and evaluate how innovations in diagnostics, therapeutics, and vaccines affect disease control.
- Assessed global tuberculosis incidence surveillance data reported for the year 2011.
- Reviewed contemporary advancements in diagnostic assays, antimicrobial drug regimens, and vaccine development alongside public health intervention strategies.
- Identified 8.7 million new cases of active tuberculosis worldwide in 2011.
- Determined that recent developments in diagnostics, therapeutic drugs, and novel vaccines, paired with expanded intervention delivery, have improved prospects for global tuberculosis containment.
Cite This Study
Zumla et al. (2013) studied this question.